The Foundation for Embryonic Competence Inc.

“Bylaws were amended and restated in june 2016 to include additional charitable & educational purposes which is to support a specialty pharmacy in the area of reproductive medicine and patient education and counseling using specialty pharmacy drugs. The support and use of specialty pharmacy products would enable use of generic delivery systems & blinded studies to enhance the integrity of the experimental designs used in studies evaluating phases of the clinical ivf process which would enhance embryo quality and implantation rates.”

“Part vi - section a- line 7athe board of directors have the right to appoint the directors and officers of the organization. The board members have 3 year terms and officers have one year terms”

“The directors and financial employee receive a copy of the form 990 for review, corrections and comments”

“The company reviews its conflict of interest policy with its directors, trustees and key employees on a yearly basis to monitor compliance. An annual conflict of interest questionnaire is completed by each director and officer to ensure that any conflicts are identified and resolved.”

“Part vi question 15ain article vii of the organizationss conflict of interest policy - periodic reviews will be conducted to ensure the organization operates in a manner consistent with charitable purposes which would include whether compensation arrangements and benefits are reasonable, based on competent survey information , and the result of arms length bargaining. When conducting this review the organization may, but need not, use outside advisors. If outside experts are used, their use shall not relieve the governing board of its responsibililty for ensuring periodic reviews are conducted. Through 9/30/15, the organization used a market survey to confirm the chief operating officers salary.”

“Part vi 15(b)see answer to 15(a) - same answer is applicable to 15(b)”

“All documents are available to the public by contacting the chief operating officer at:140 allen roadbasking ridge, nj 07920the public can receive this information through the foundations website www.faeec.org”

“Part 1 line 1 and part iii line 1 - organizations missionprovide broad access to contemporary embryo and single gene defect diagnostics, which are not commonly provided within art clinics; sponsor clinical research into new embryo diagnostics; provide continuing medical education and graduate fellowship education related to the application of diagnostics used to assess embryonic reproductive competence. Support specialty pharmacy in the area of reproductive medicine, which can provide comparative support for studies where medications need to be blinded. The support of specialty pharmacy is critical in studies evaluating phases of the clinical ivf process, which would enhance embryo quality or implantation rates. Given the virtual impossibility of performing blinded studies in the field, due to the use of injectables and suppositories with specific packaging and delivery materials, the support and use of specialty pharmacy products would enable the use of generic delivery systems and blinded studies to enhance the integrity of the experimental designs used in these studies. Provide patient education regarding the use of specialty pharmacy drugs and medications in support of embryonic and single gene testing protocols. The wide stream dissemination of educational materials and patient counseling through the foundation, produced in conjunction with specialty pharmacies, will enhance and support current clinical medications and protocols, teach, train and follow up with patients regarding possible side effects or complications, research protocols performed by the foundation, result in superior patient outcomes, and ensure the long term safety of ivf patients. Develop direct business relationships with specialty pharmacies so as to generate specialty pharmacy patient data from across varied demographic plains in order to provide the foundation timely data on protocols, trends, prescribing practices and many other potentially valuable facets of information to be used to enhance patient outcomes and research protocols.”